Mineralys Therapeutics, Inc. (MLYS) Tops Q1 EPS by 29c

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) reported Q1 EPS of ($0.79), $0.29 better than the analyst estimate of ($1.08).

For earnings history and earnings-related data on Mineralys Therapeutics, Inc. (MLYS) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Boeing workers reject contract, authorize strike
• enVVeno Medical (NVNO) files $100M mixed shelf